Skip to main content
PolicySpeak
← All files
EH

EIT Health

Other · Germany · EU Transparency Register 781385241347-65not in register snapshot

This register number is the organization’s own declaration on its submission. It is not in the 14 Oct 2026 snapshot of the EU Transparency Register, so we neither link to it nor use it to identify this organization.

10
positions filed
in the 665 files tracked
8
legislative files
of 665 tracked
10
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Track EIT in PolicySpeak: request access →

Follow EIT Health

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at EIT Health? so we know who speaks for it.

Their record over time

EIT Health filed 10 positions between 2 Feb 2021 and 23 Sept 2026, across 8 of the 665 legislative files tracked here, attaching a full position paper 10 times.

2021 · 4 filed2022 · 2 filed2025 · 1 filed2026 · 3 filed

What they argued

Artificial Intelligence Actfiled 29 Jul 2021PDFsource

• EIT Health welcomes the proposed AI Regulation and its ambition to create horizontal legislation overseeing AI and to maximise the safety and trustworthiness of this technology. We welcome the creation of a risk-classification of AI and prohibition of certain AI in alignment with the OECD, as this type of risk management is vital to ensuring uptake of this important technology.

European Biotech Actfiled 26 Mar 2026PDFsource

EIT Health welcomes the Commissions Biotech Act proposal to boost European competitiveness & innovation, via the biotech sector. The key drivers outlined by the Commission are explored in a recent EIT Health Think Tank report, Skills, scale and science: Uniting European Innovation Ecosystems through the Biotech Act, by industry experts.

European Biotech Actfiled 11 Jun 2025PDFsource

EIT Health welcomes the commitment to reinforce Europes competitiveness through the Biotech Act. The European biotech sector has the potential to transform health outcomes, strengthen Europes strategic autonomy, and drive competitiveness. Small start-ups and SMEs require specific policy support and are disproportionately impacted by a number of issues.

EU Teachers Agenda: Enhancing the attractiveness of the education and training professionfiled 8 Sept 2026PDFsource

EIT Health welcomes the Commission's efforts to strengthen basic skills and improve educational outcomes across Europe. From our experience supporting innovation, education and skills development across the health sector, we observe that the accelerating pace of technological and societal change requires learners to develop not only strong foundational skills, but also adaptability, critical thinking, creativity and…

European Health Data Spacefiled 6 May 2022PDFsource

EIT Health welcomes the publication of EHDS proposal, a key building block for the creation of a sustainable and resilient European Health Union, and an unprecedented opportunity to leverage the European power to innovate.

European Health Data Spacefiled 3 Feb 2021PDFsource

EIT Health European Health Data Space Consultation Response • The EHDS will be an important part of Europe’s health research and innovation landscape which will support the development of many innovative treatments and interventions which will improve outcomes, health and quality of life.

European data governance (Data Governance Act)filed 5 Feb 2021PDFsource

• EIT Health welcomes the legislative proposal for the Data Governance Act (DGA), noting that it provides for the adoption of sector specific legislation for sectoral data spaces which will build on the provisions of the DGA and will apply in complement to it. EIT Health looks forward to providing comment on such draft legislation.

Revision of the EIT Regulation and of the Strategic Innovation Agendafiled 23 Sept 2026PDFsource

EIT Health is the health-focused Knowledge and Innovation Community (KIC) of the European Institute of Innovation and Technology (EIT). It brings together organisations from business, research, education and healthcare delivery to address major health challenges while strengthening Europe's competitiveness through innovation, entrepreneurship, investment and skills development.

European Year of Skills 2023filed 14 Dec 2022PDFsource

The EIT (European Institute of Innovation and Technology) KICs (Knowledge and Innovation Communities) welcome 2023 as the European Year of Skills. The EIT KICs appreciate the European Unions intention to invest and catalyse efforts in education and lifelong learning.

Serious cross-border threats to healthfiled 2 Feb 2021PDFsource

EIT Health Response to Consultation on Proposal for a Regulation on Serious Cross-border Health Threats • In early 2020, Europe, along with the rest of the world, was struck by the greatest public health challenge of recent times – a pandemic of global proportions. COVID-19 posed a significant threat to our society, our economy, and our way of life. During the pandemic agility and speed were of critical importance.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put EIT Health next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.

Showing 5 of 153.

Is this your organization?

Everything on this page comes from EIT Health’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.